'Kaposi sarcoma' diaporamas de présentation

Skin

1.04k views • 73 slides

Kaposi sarcoma as indicator disease for HIV prevalence in the Netherlands

323 views • 32 slides

Oral Epithelial Tumours

623 views • 30 slides

From anomalous cell cycle regulation to malignant tumors

From anomalous cell cycle regulation to malignant tumors. Regulation of cell proliferation Regulation of cell death Oncogenes and tumor suppressors viral oncogenes Telomerase activity Angiogenesis Immune modulation Metastasis Multi drug resistance Genetic instability.

442 views • 30 slides

Kaposis Sarcoma

Kaposi's sarcoma is a important opportunistic viral infection in particular infecting the AIDS patients

2.04k views • 28 slides

Pathology of Blood Vessels

Pathology of Blood Vessels. LECTURE - 6 Learning objectives. Vascular tumours Introduction Classification Some types. Wide spectrum: benign hemangioma to intermediate , highly malignant Congenital malformations/tumours

401 views • 27 slides

UVEAL INFECTIONS AND INFESTATIONS

UVEAL INFECTIONS AND INFESTATIONS. 1. Viruses. Herpes zoster ophthalmicus Acute retinal necrosis Cytomegalovirus (CMV). 2. Spirochaetes. Syphilis Lyme disease. 3. Mycobacteria. Tuberculosis Leprosy. 4. Protozoa and worms. Toxoplasmosis Ocular toxocariasis. 5. Fungi.

1.1k views • 27 slides

Dante Luiz Escuissato

Dante Luiz Escuissato. Infections are related to specific immunity defects. Phagocyte abnormalities and intravenous catheters: Aspergillus and Candida species.

327 views • 23 slides

Current CED Data Sources

l. CED Data Sources AHRQ Annual Conference September 2010 James A Rollins, MD, MSHA, PhD Coverage and Analysis Group Office of Clinical Standards and Quality Centers for Medicare & Medicaid Services. Current CED Data Sources. ICD Registry

279 views • 19 slides

Chapter 6.2 Sexually Transmitted Diseases (Online Learning)

Chapter 6.2 Sexually Transmitted Diseases (Online Learning). Learning Objectives. By the end of the lesson, you should be able to : state the harmful consequences of sexually transmitted disease like: syphilis g onorrhea AIDS

192 views • 11 slides

Global  Kaposi Sarcoma Market Outlook 2024: Global Opportunity & Growth Analysis, 2016-2024

Kaposi sarcoma market has increased at a CAGR of 2.25% over the forecast period that will exhibit valuation of USD 0.15 billion by 2024 rising from USD 0.11 billion in 2016

121 views • 10 slides

Kaposi Sarcoma Market will rise to US$ 143.2 Million by 2024

According to the research report, the global Kaposi sarcoma market is projected to rise from US$118.5 million in 2015 to reach US$143.2 million in 2024 at a modest CAGR of 2.2% from 2016 to 2024.

71 views • 4 slides

Kaposi Sarcoma Market Revenue, Growth Rate, And Applications By 2025

Kaposi Sarcoma is a tumor caused by infection with human herpes virus 8. It is also known as Kaposi sarcoma-associated herpes virus or KS agent.

42 views • 4 slides

Infections Acquired in T Cell Deficiency

Infections Acquired in T Cell Deficiency. Pneumocyctic jirovecii Candidiasis Acinetobacter baumanii Toxoplasma gondii Aspergillus Mucor Kaposi Sarcoma Cytomegalovirus.

171 views • 1 slides